Usefulness of Dose Intensity/Body Surface Area Ratio (DI/BSA Ratio; DBR) Rather Than Relative Dose Intensity in the Lenvatinib Treatment for Hepatocellular Carcinoma

Acta Hepatologica Japonica - Japan
doi 10.2957/kanzo.61.129
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Japan Society of Hepatology

Related search

Dose Intensity/Body Surface Area Ratio Is a Novel Marker Useful for Predicting Response to Lenvatinib Against Hepatocellular Carcinoma

Cancers
Cancer ResearchOncology
2019English

Dose Intensity of Chemotherapy for Childhood Cancers

Oncologist
Cancer ResearchMedicineOncology
1996English

Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Plateletto- Lymphocyte Ratio in Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Oncotarget
Oncology
2018English

Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma

Future Oncology
MedicineCancer ResearchOncology
2018English

Association of Reduced Relative Dose Intensity and Survival in Lymphoma Patients Receiving CHOP-21 Chemotherapy

Annals of Hematology
MedicineHematology
2008English

Is Higher Dose Always the Right Answer in Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma?

Radiation Oncology Journal
OncologyRadiologyNuclear MedicineImaging
2018English

High-Dose-Rate Intracavitary Brachytherapy Boost in Addition to Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Impact of Adaptive Intensity-Modulated Radiotherapy on the Neutrophil-To-Lymphocyte Ratio in Patients With Nasopharyngeal Carcinoma

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Ratio Scaling of Taste Intensity by a Matching Procedure

Perception & Psychophysics
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy